Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | PGR | P06401 | 2/20 | 0.46 |
| ▸ | PTGER4 | P35408 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.35 |
| ▸ | TSPO | P30536 | 1/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | KDR | P35968 | 1/20 | 0.34 |
| ▸ | RORC | P51449 | 2/20 | 0.34 |
| ▸ | METAP2 | P50579 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15248614 | 0.97 | L3MBTL1 (0.51) | L3MBTL1KDM4EATMPGRPTGER4 | |
| SCHEMBL15248318 | 0.96 | L3MBTL1 (0.50) | L3MBTL1KDM4EATMPGRPTGER4 | |
| SCHEMBL17950375 | 0.96 | PGR (0.49) | L3MBTL1KDM4EATMPGRALDH1A1 | |
| SCHEMBL15250659 | 0.94 | L3MBTL1 (0.49) | L3MBTL1KDM4EATMPGRPTGER4 | |
| SCHEMBL19177003 | 0.94 | L3MBTL1 (0.49) | L3MBTL1KDM4EATMPGRPTGER4 | |
| SCHEMBL15248250 | 0.94 | L3MBTL1 (0.49) | L3MBTL1KDM4EATMPGRPTGER4 | |
| SCHEMBL15250590 | 0.94 | L3MBTL1 (0.51) | L3MBTL1KDM4EATMPGRPTGER4 | |
| SCHEMBL17935127 | 0.94 | L3MBTL1 (0.51) | L3MBTL1KDM4EATMPGRPTGER4 | |
| SCHEMBL17950407 | 0.94 | PGR (0.48) | L3MBTL1KDM4EATMPGRALDH1A1 | |
| SCHEMBL17950376 | 0.94 | ATM (0.45) | L3MBTL1KDM4EATMPGRPTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220213113-A1 | NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2022-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220213113-A1 | NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | NCL, NOC2L, NOLC1 | L3MBTL1 2377/4885KDM4E 3163/4885ATM 953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.